|
Bacil Pharma Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
69.84 Cr.
|
P/BV
|
2.61
|
Book Value (Rs.)
|
18.65
|
|
52 Week High/Low (Rs.)
|
52/27
|
FV/ML
|
10/1
|
P/E(X)
|
173.17
|
|
Bookclosure
|
27/09/2024
|
EPS (Rs.)
|
0.28
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Employees Cost | 0.04 | 0.10 | 0.06 | 0.06 | 0.04 |
| Other Expenses | 0.13 | 0.08 | 0.06 | 0.07 | 0.13 |
| Total Expenses | 0.17 | 0.18 | 0.13 | 0.13 | 0.17 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.17 | -0.18 | -0.13 | -0.13 | -0.17 |
| Other Income | 1.12 | 0.57 | 0.11 | 0.11 | 0.05 |
| P/L Before Interest, Excpt. Items & Tax | 0.95 | 0.39 | -0.02 | -0.03 | -0.12 |
| P/L Before Exceptional Items & Tax | 0.95 | 0.39 | -0.02 | -0.03 | -0.12 |
| P/L Before Tax | 0.95 | 0.39 | -0.02 | -0.03 | -0.12 |
| Tax | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 |
| P/L After Tax from Ordinary Activities | 0.72 | 0.39 | -0.02 | -0.03 | -0.12 |
| Net Profit/Loss For the Period | 0.72 | 0.39 | -0.02 | -0.03 | -0.12 |
| | | | | | |
| Equity Share Capital | 13.97 | 5.89 | 5.89 | 5.89 | 5.89 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 0.51 | 0.66 | -0.03 | -0.04 | -0.21 |
| Diluted EPS (Rs.) | 0.52 | 0.66 | -0.03 | -0.04 | -0.21 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 0.51 | 0.66 | -0.03 | -0.04 | -0.21 |
| Diluted EPS (Rs.) | 0.00 | 0.66 | -0.03 | -0.04 | -0.21 |
